Refanalin for Liver Transplantation

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$1,398,780.00
Award Year:
2004
Program:
SBIR
Phase:
Phase II
Contract:
2R44AA014718-02
Agency Tracking Number:
AA014718
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
ANGION BIOMEDICA CORPORATION
ANGION BIOMEDICA CORP, 350 COMMUNITY DR, RM 129, MANHASSET, NY, 11030
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
WEIZHONG Cai
(516) 562-1140
wcai@angion.com
Business Contact:
ITZHAK GOLDBERG
(516) 869-6400
GOLDBERG@ANGION.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Orthotopic liver transplantation is the most effective treatment for patients with end-stage liver disease. Ischemia-reperfusion injury associated with the retrieval, storage and transplantation of livers is a major

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government